 Alexander Barker
Concepts (434)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 68 | 2025 | 364 | 11.200 |
Why?
| | Heart Valve Diseases | 53 | 2024 | 151 | 9.310 |
Why?
| | Hemodynamics | 79 | 2025 | 1118 | 8.480 |
Why?
| | Magnetic Resonance Angiography | 44 | 2025 | 251 | 7.400 |
Why?
| | Aorta | 57 | 2026 | 441 | 7.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 39 | 2025 | 214 | 6.410 |
Why?
| | Imaging, Three-Dimensional | 57 | 2026 | 583 | 5.930 |
Why?
| | Magnetic Resonance Imaging | 83 | 2026 | 3916 | 5.490 |
Why?
| | Blood Flow Velocity | 77 | 2026 | 421 | 5.410 |
Why?
| | Aortic Valve Stenosis | 24 | 2026 | 256 | 3.840 |
Why?
| | Image Interpretation, Computer-Assisted | 30 | 2025 | 289 | 3.830 |
Why?
| | Aorta, Thoracic | 23 | 2023 | 287 | 3.670 |
Why?
| | Aortic Diseases | 23 | 2024 | 125 | 3.610 |
Why?
| | Stress, Mechanical | 33 | 2024 | 494 | 2.730 |
Why?
| | Ventricular Function, Left | 17 | 2025 | 544 | 2.310 |
Why?
| | Predictive Value of Tests | 36 | 2025 | 2123 | 2.060 |
Why?
| | Tetralogy of Fallot | 9 | 2025 | 78 | 1.980 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2023 | 138 | 1.940 |
Why?
| | Regional Blood Flow | 23 | 2025 | 514 | 1.890 |
Why?
| | Pulmonary Artery | 17 | 2024 | 1129 | 1.890 |
Why?
| | Fetal Heart | 4 | 2025 | 56 | 1.850 |
Why?
| | Shear Strength | 15 | 2024 | 73 | 1.800 |
Why?
| | Myocardial Perfusion Imaging | 9 | 2025 | 50 | 1.720 |
Why?
| | Vascular Stiffness | 17 | 2024 | 487 | 1.590 |
Why?
| | Heart Ventricles | 17 | 2024 | 756 | 1.460 |
Why?
| | Pulmonary Circulation | 7 | 2025 | 430 | 1.440 |
Why?
| | Echocardiography, Doppler | 5 | 2024 | 115 | 1.410 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2025 | 394 | 1.330 |
Why?
| | Reproducibility of Results | 33 | 2025 | 3418 | 1.300 |
Why?
| | Models, Cardiovascular | 12 | 2021 | 196 | 1.300 |
Why?
| | Image Enhancement | 12 | 2022 | 200 | 1.240 |
Why?
| | Perfusion Imaging | 14 | 2024 | 66 | 1.230 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 119 | 1.190 |
Why?
| | Humans | 197 | 2026 | 145783 | 1.140 |
Why?
| | Ultrasonography, Prenatal | 4 | 2025 | 295 | 1.130 |
Why?
| | Heart Valve Prosthesis Implantation | 7 | 2025 | 198 | 1.070 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2025 | 48 | 1.070 |
Why?
| | Female | 129 | 2026 | 79045 | 1.040 |
Why?
| | Echocardiography, Four-Dimensional | 3 | 2024 | 9 | 1.010 |
Why?
| | Fontan Procedure | 9 | 2025 | 192 | 1.010 |
Why?
| | Aortic Coarctation | 8 | 2025 | 78 | 0.980 |
Why?
| | Heart Defects, Congenital | 13 | 2025 | 910 | 0.970 |
Why?
| | Male | 126 | 2026 | 73011 | 0.950 |
Why?
| | Cardiac-Gated Imaging Techniques | 10 | 2025 | 21 | 0.930 |
Why?
| | Contrast Media | 11 | 2022 | 497 | 0.910 |
Why?
| | Hypertension, Pulmonary | 11 | 2023 | 1957 | 0.910 |
Why?
| | Image Processing, Computer-Assisted | 11 | 2025 | 783 | 0.900 |
Why?
| | Terminology as Topic | 4 | 2024 | 259 | 0.890 |
Why?
| | Gestational Age | 4 | 2025 | 990 | 0.860 |
Why?
| | Retrospective Studies | 51 | 2025 | 17330 | 0.850 |
Why?
| | Cardiac Catheterization | 7 | 2025 | 559 | 0.840 |
Why?
| | Adult | 74 | 2025 | 40881 | 0.840 |
Why?
| | Ventricular Function, Right | 12 | 2024 | 297 | 0.780 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.760 |
Why?
| | Middle Aged | 66 | 2026 | 36309 | 0.740 |
Why?
| | Coronary Circulation | 10 | 2020 | 134 | 0.730 |
Why?
| | Observer Variation | 6 | 2023 | 357 | 0.730 |
Why?
| | Child | 45 | 2025 | 22740 | 0.690 |
Why?
| | Case-Control Studies | 22 | 2025 | 3634 | 0.690 |
Why?
| | Overweight | 2 | 2025 | 614 | 0.680 |
Why?
| | Young Adult | 41 | 2024 | 14254 | 0.660 |
Why?
| | Hydrodynamics | 4 | 2022 | 50 | 0.660 |
Why?
| | Sensitivity and Specificity | 15 | 2016 | 2000 | 0.660 |
Why?
| | Ventricular Dysfunction, Right | 6 | 2022 | 248 | 0.650 |
Why?
| | Problem-Based Learning | 1 | 2021 | 97 | 0.650 |
Why?
| | Cardiac Surgical Procedures | 5 | 2020 | 611 | 0.640 |
Why?
| | Motion Pictures | 1 | 2020 | 20 | 0.630 |
Why?
| | Adolescent | 43 | 2025 | 22577 | 0.630 |
Why?
| | Reference Values | 9 | 2024 | 798 | 0.620 |
Why?
| | Electrocardiography | 4 | 2020 | 668 | 0.620 |
Why?
| | Arterial Pressure | 7 | 2019 | 134 | 0.610 |
Why?
| | Tobacco Use | 1 | 2020 | 62 | 0.610 |
Why?
| | Nuclear Physics | 6 | 2014 | 13 | 0.600 |
Why?
| | Tobacco Products | 1 | 2020 | 84 | 0.590 |
Why?
| | Algorithms | 12 | 2025 | 1851 | 0.570 |
Why?
| | Aged | 42 | 2026 | 26217 | 0.560 |
Why?
| | Kidney | 2 | 2025 | 1497 | 0.550 |
Why?
| | Anesthesia | 1 | 2022 | 257 | 0.540 |
Why?
| | Pulse Wave Analysis | 9 | 2023 | 267 | 0.540 |
Why?
| | Severity of Illness Index | 12 | 2025 | 2933 | 0.530 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2024 | 119 | 0.490 |
Why?
| | Models, Theoretical | 7 | 2017 | 560 | 0.490 |
Why?
| | Cardiac Imaging Techniques | 8 | 2021 | 24 | 0.480 |
Why?
| | Aortography | 3 | 2021 | 52 | 0.470 |
Why?
| | Aortic Aneurysm | 6 | 2024 | 70 | 0.470 |
Why?
| | C-Peptide | 2 | 2014 | 190 | 0.460 |
Why?
| | Systole | 9 | 2022 | 181 | 0.450 |
Why?
| | Gadolinium DTPA | 2 | 2018 | 70 | 0.440 |
Why?
| | Prospective Studies | 18 | 2024 | 8078 | 0.440 |
Why?
| | Arteriosclerosis | 2 | 2014 | 83 | 0.430 |
Why?
| | Age Factors | 12 | 2025 | 3346 | 0.430 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2025 | 2602 | 0.400 |
Why?
| | Feasibility Studies | 10 | 2019 | 1115 | 0.400 |
Why?
| | Elementary Particles | 4 | 2014 | 12 | 0.400 |
Why?
| | Hemorheology | 1 | 2013 | 24 | 0.400 |
Why?
| | Dilatation, Pathologic | 7 | 2024 | 61 | 0.400 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2191 | 0.400 |
Why?
| | Aging | 2 | 2015 | 1973 | 0.400 |
Why?
| | Marfan Syndrome | 3 | 2018 | 46 | 0.390 |
Why?
| | Stroke Volume | 9 | 2022 | 655 | 0.390 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.380 |
Why?
| | Child, Preschool | 18 | 2025 | 11868 | 0.380 |
Why?
| | Insulin Antibodies | 1 | 2013 | 103 | 0.380 |
Why?
| | Computer Simulation | 6 | 2021 | 1003 | 0.380 |
Why?
| | Norwood Procedures | 2 | 2024 | 33 | 0.370 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2024 | 3937 | 0.370 |
Why?
| | Hyperventilation | 1 | 2012 | 15 | 0.370 |
Why?
| | Insulin-Secreting Cells | 2 | 2014 | 392 | 0.360 |
Why?
| | Pilot Projects | 10 | 2022 | 1898 | 0.340 |
Why?
| | Acceleration | 1 | 2011 | 33 | 0.340 |
Why?
| | Heart Valve Prosthesis | 4 | 2017 | 129 | 0.340 |
Why?
| | Awareness | 1 | 2012 | 110 | 0.340 |
Why?
| | Vascular Remodeling | 5 | 2019 | 209 | 0.330 |
Why?
| | Cross-Sectional Studies | 8 | 2025 | 5925 | 0.320 |
Why?
| | Phantoms, Imaging | 5 | 2022 | 159 | 0.310 |
Why?
| | Mitral Valve Stenosis | 2 | 2022 | 20 | 0.310 |
Why?
| | Artifacts | 4 | 2025 | 143 | 0.300 |
Why?
| | Fetus | 2 | 2025 | 804 | 0.300 |
Why?
| | Phenotype | 9 | 2021 | 3170 | 0.300 |
Why?
| | Biomechanical Phenomena | 6 | 2023 | 860 | 0.290 |
Why?
| | Electroencephalography | 1 | 2012 | 563 | 0.280 |
Why?
| | Cardiovascular System | 2 | 2023 | 139 | 0.280 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 290 | 0.280 |
Why?
| | Time Factors | 15 | 2025 | 7134 | 0.260 |
Why?
| | Echocardiography | 7 | 2025 | 648 | 0.250 |
Why?
| | Heart Function Tests | 2 | 2019 | 59 | 0.250 |
Why?
| | Ventricular Remodeling | 5 | 2022 | 278 | 0.250 |
Why?
| | Principal Component Analysis | 2 | 2024 | 194 | 0.240 |
Why?
| | Postoperative Complications | 5 | 2020 | 2977 | 0.240 |
Why?
| | Follow-Up Studies | 8 | 2025 | 5428 | 0.240 |
Why?
| | Oxygen Consumption | 2 | 2025 | 719 | 0.220 |
Why?
| | Biomarkers | 8 | 2023 | 4302 | 0.220 |
Why?
| | Cardiorespiratory Fitness | 1 | 2025 | 74 | 0.220 |
Why?
| | Prenatal Diagnosis | 2 | 2025 | 196 | 0.220 |
Why?
| | Blood Circulation | 1 | 2024 | 44 | 0.220 |
Why?
| | Renal Circulation | 1 | 2025 | 75 | 0.220 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2019 | 228 | 0.210 |
Why?
| | Neoplasm, Residual | 1 | 2025 | 143 | 0.210 |
Why?
| | Infant, Newborn | 5 | 2023 | 6465 | 0.210 |
Why?
| | Cross-Over Studies | 2 | 2024 | 610 | 0.210 |
Why?
| | Placental Circulation | 1 | 2025 | 71 | 0.210 |
Why?
| | Viscosity | 3 | 2019 | 92 | 0.210 |
Why?
| | Myocardial Contraction | 3 | 2020 | 293 | 0.210 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 126 | 0.210 |
Why?
| | Marketing | 1 | 2024 | 23 | 0.210 |
Why?
| | Exome | 1 | 2025 | 229 | 0.200 |
Why?
| | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2024 | 5 | 0.200 |
Why?
| | Rheology | 2 | 2017 | 94 | 0.200 |
Why?
| | Hypoglycemic Agents | 1 | 2013 | 1399 | 0.200 |
Why?
| | Ultrasonography | 3 | 2017 | 788 | 0.200 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2015 | 143 | 0.200 |
Why?
| | Microvessels | 1 | 2025 | 97 | 0.200 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 156 | 0.200 |
Why?
| | Arteries | 2 | 2018 | 261 | 0.200 |
Why?
| | Elementary Particle Interactions | 2 | 2013 | 5 | 0.190 |
Why?
| | Carotid Arteries | 2 | 2017 | 208 | 0.190 |
Why?
| | Protein Corona | 1 | 2022 | 9 | 0.190 |
Why?
| | Insulin | 2 | 2013 | 2516 | 0.190 |
Why?
| | Peroneal Neuropathies | 1 | 2022 | 2 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.180 |
Why?
| | Motor Neuron Disease | 1 | 2022 | 20 | 0.180 |
Why?
| | Iodine Radioisotopes | 1 | 2022 | 138 | 0.180 |
Why?
| | Infant | 10 | 2024 | 10091 | 0.180 |
Why?
| | Radiculopathy | 1 | 2022 | 38 | 0.180 |
Why?
| | Respiratory-Gated Imaging Techniques | 3 | 2018 | 10 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2770 | 0.180 |
Why?
| | Osseointegration | 1 | 2022 | 60 | 0.180 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 68 | 0.180 |
Why?
| | Pregnancy | 6 | 2025 | 7216 | 0.180 |
Why?
| | Oxygen | 2 | 2025 | 981 | 0.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 920 | 0.180 |
Why?
| | Biomedical Engineering | 1 | 2021 | 30 | 0.170 |
Why?
| | Coronary Vessels | 2 | 2021 | 246 | 0.170 |
Why?
| | Prenatal Care | 1 | 2024 | 309 | 0.170 |
Why?
| | Nanostructures | 1 | 2022 | 105 | 0.170 |
Why?
| | Healthy Volunteers | 3 | 2017 | 219 | 0.170 |
Why?
| | Body Fluids | 1 | 2021 | 71 | 0.170 |
Why?
| | Medicago truncatula | 1 | 2021 | 2 | 0.170 |
Why?
| | Respiration | 1 | 2022 | 207 | 0.170 |
Why?
| | Anesthesia, General | 1 | 2022 | 121 | 0.170 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 765 | 0.170 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 34 | 0.160 |
Why?
| | Bioprosthesis | 3 | 2015 | 39 | 0.160 |
Why?
| | Lower Extremity | 1 | 2025 | 450 | 0.160 |
Why?
| | Glycopeptides | 1 | 2021 | 45 | 0.160 |
Why?
| | Creatinine | 1 | 2022 | 515 | 0.160 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.160 |
Why?
| | Heme | 1 | 2021 | 90 | 0.160 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 109 | 0.160 |
Why?
| | Plant Proteins | 1 | 2021 | 111 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 2 | 2018 | 43 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2025 | 381 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 337 | 0.160 |
Why?
| | Students, Pharmacy | 1 | 2021 | 96 | 0.150 |
Why?
| | Sinus of Valsalva | 1 | 2019 | 11 | 0.150 |
Why?
| | Faculty | 1 | 2021 | 148 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 486 | 0.150 |
Why?
| | Radiography | 3 | 2024 | 853 | 0.150 |
Why?
| | Intracranial Aneurysm | 1 | 2021 | 106 | 0.150 |
Why?
| | Mechanotransduction, Cellular | 1 | 2021 | 121 | 0.150 |
Why?
| | Anti-Infective Agents | 1 | 2022 | 232 | 0.150 |
Why?
| | Disease Progression | 7 | 2025 | 2865 | 0.150 |
Why?
| | Education, Pharmacy | 1 | 2021 | 120 | 0.150 |
Why?
| | United Kingdom | 1 | 2020 | 358 | 0.150 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2022 | 37 | 0.150 |
Why?
| | Blood Volume | 2 | 2016 | 65 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 593 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 102 | 0.140 |
Why?
| | Transcriptome | 1 | 2025 | 1042 | 0.140 |
Why?
| | Aorta, Abdominal | 2 | 2015 | 52 | 0.140 |
Why?
| | Elastic Tissue | 1 | 2018 | 10 | 0.140 |
Why?
| | Hemoglobins | 1 | 2021 | 386 | 0.140 |
Why?
| | Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.140 |
Why?
| | Endothelium, Vascular | 2 | 2016 | 956 | 0.140 |
Why?
| | Tricuspid Valve | 2 | 2015 | 43 | 0.140 |
Why?
| | Muscarinic Antagonists | 1 | 1998 | 30 | 0.140 |
Why?
| | Pharmacists | 1 | 2021 | 258 | 0.130 |
Why?
| | Placenta | 1 | 2025 | 787 | 0.130 |
Why?
| | Anxiety Disorders | 1 | 2021 | 371 | 0.130 |
Why?
| | Turner Syndrome | 1 | 2018 | 65 | 0.130 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 67 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 699 | 0.130 |
Why?
| | Prognosis | 7 | 2021 | 4330 | 0.130 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 94 | 0.130 |
Why?
| | Alcoholism | 1 | 2024 | 826 | 0.130 |
Why?
| | Aged, 80 and over | 6 | 2026 | 8347 | 0.120 |
Why?
| | Alcohol Drinking | 1 | 2024 | 843 | 0.120 |
Why?
| | Peptide Fragments | 1 | 2021 | 697 | 0.120 |
Why?
| | Motion | 3 | 2025 | 95 | 0.120 |
Why?
| | Sleep | 1 | 2024 | 889 | 0.120 |
Why?
| | Mesons | 2 | 2014 | 9 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2023 | 680 | 0.120 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 140 | 0.120 |
Why?
| | Treatment Outcome | 9 | 2025 | 11794 | 0.120 |
Why?
| | Blood Pressure | 3 | 2019 | 1782 | 0.120 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 1 | 2016 | 15 | 0.120 |
Why?
| | Cryptorchidism | 1 | 2016 | 16 | 0.120 |
Why?
| | Thoracic Surgery | 1 | 2018 | 143 | 0.120 |
Why?
| | Mitral Valve | 1 | 2017 | 95 | 0.120 |
Why?
| | Endocardium | 1 | 2016 | 31 | 0.120 |
Why?
| | Heart Rate | 1 | 2020 | 856 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 892 | 0.120 |
Why?
| | Hypospadias | 1 | 2016 | 31 | 0.120 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 428 | 0.120 |
Why?
| | Analysis of Variance | 3 | 2014 | 1300 | 0.120 |
Why?
| | Pregnancy Trimester, First | 1 | 2016 | 139 | 0.110 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2015 | 4 | 0.110 |
Why?
| | Splanchnic Circulation | 1 | 2015 | 12 | 0.110 |
Why?
| | Femoral Artery | 2 | 2013 | 190 | 0.110 |
Why?
| | Cerebrovascular Disorders | 1 | 2016 | 105 | 0.110 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 146 | 0.110 |
Why?
| | Preoperative Care | 1 | 2017 | 380 | 0.110 |
Why?
| | Angiography | 1 | 2015 | 208 | 0.110 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 38 | 0.110 |
Why?
| | Cohort Studies | 5 | 2021 | 6033 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 719 | 0.110 |
Why?
| | Portal Vein | 2 | 2015 | 117 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 528 | 0.110 |
Why?
| | Neutrons | 1 | 2014 | 10 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 750 | 0.100 |
Why?
| | Atherosclerosis | 2 | 2021 | 409 | 0.100 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 252 | 0.100 |
Why?
| | Brain Mapping | 1 | 2017 | 542 | 0.100 |
Why?
| | Databases, Factual | 2 | 2017 | 1491 | 0.100 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2014 | 38 | 0.100 |
Why?
| | Heart | 3 | 2023 | 626 | 0.100 |
Why?
| | Subtraction Technique | 1 | 2013 | 26 | 0.100 |
Why?
| | Consensus | 3 | 2021 | 479 | 0.100 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 123 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1477 | 0.100 |
Why?
| | Carotid Artery, Internal | 1 | 2013 | 45 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 196 | 0.090 |
Why?
| | Endarterectomy, Carotid | 1 | 2013 | 64 | 0.090 |
Why?
| | Multimodal Imaging | 1 | 2013 | 129 | 0.090 |
Why?
| | Epilepsy, Partial, Motor | 1 | 2012 | 2 | 0.090 |
Why?
| | Europe | 1 | 2013 | 421 | 0.090 |
Why?
| | Plaque, Atherosclerotic | 1 | 2013 | 61 | 0.090 |
Why?
| | Epilepsy, Absence | 1 | 2012 | 12 | 0.090 |
Why?
| | Brain | 1 | 2025 | 2969 | 0.090 |
Why?
| | Protons | 1 | 2013 | 96 | 0.090 |
Why?
| | Vascular Capacitance | 1 | 2012 | 4 | 0.090 |
Why?
| | Carotid Stenosis | 1 | 2013 | 107 | 0.090 |
Why?
| | Fasting | 1 | 2013 | 279 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 557 | 0.090 |
Why?
| | Pulmonary Embolism | 1 | 2014 | 241 | 0.090 |
Why?
| | Signal-To-Noise Ratio | 2 | 2025 | 73 | 0.090 |
Why?
| | Systematized Nomenclature of Medicine | 2 | 2021 | 13 | 0.090 |
Why?
| | Alzheimer Disease | 1 | 1998 | 630 | 0.090 |
Why?
| | Surface Properties | 2 | 2022 | 386 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2016 | 878 | 0.080 |
Why?
| | Vasodilation | 1 | 2013 | 521 | 0.080 |
Why?
| | Dilatation | 2 | 2021 | 73 | 0.080 |
Why?
| | Diastole | 2 | 2020 | 146 | 0.080 |
Why?
| | RNA | 1 | 2016 | 912 | 0.070 |
Why?
| | Neoplasms | 1 | 2025 | 2913 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2968 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2028 | 0.070 |
Why?
| | Patient-Specific Modeling | 2 | 2020 | 45 | 0.070 |
Why?
| | Swine | 3 | 2016 | 826 | 0.070 |
Why?
| | Linear Models | 3 | 2017 | 849 | 0.070 |
Why?
| | Risk Factors | 6 | 2020 | 10919 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 485 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2399 | 0.060 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 568 | 0.060 |
Why?
| | Calibration | 2 | 2017 | 152 | 0.060 |
Why?
| | Prostheses and Implants | 2 | 2022 | 137 | 0.060 |
Why?
| | Peripheral Arterial Disease | 1 | 2013 | 509 | 0.060 |
Why?
| | Sheep | 2 | 2022 | 876 | 0.060 |
Why?
| | Blood Volume Determination | 2 | 2016 | 4 | 0.060 |
Why?
| | Body Mass Index | 1 | 2014 | 2447 | 0.060 |
Why?
| | Liquid Biopsy | 1 | 2025 | 15 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1211 | 0.060 |
Why?
| | Vena Cava, Inferior | 2 | 2016 | 83 | 0.050 |
Why?
| | Elasticity | 2 | 2017 | 189 | 0.050 |
Why?
| | Cardiac Output | 1 | 2025 | 179 | 0.050 |
Why?
| | Patient Positioning | 1 | 2025 | 70 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1777 | 0.050 |
Why?
| | Organometallic Compounds | 2 | 2018 | 113 | 0.050 |
Why?
| | Stroke | 1 | 2013 | 1271 | 0.050 |
Why?
| | Alcoholic Beverages | 1 | 2024 | 31 | 0.050 |
Why?
| | Neural Conduction | 1 | 2024 | 92 | 0.050 |
Why?
| | Pulsatile Flow | 2 | 2015 | 61 | 0.050 |
Why?
| | Technology | 1 | 2024 | 97 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 148 | 0.050 |
Why?
| | Animals | 8 | 2022 | 38102 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 31 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2025 | 283 | 0.050 |
Why?
| | Risk Assessment | 3 | 2018 | 3752 | 0.050 |
Why?
| | Kinetics | 1 | 2026 | 1568 | 0.050 |
Why?
| | Fasciculation | 1 | 2022 | 2 | 0.050 |
Why?
| | Durapatite | 1 | 2022 | 37 | 0.050 |
Why?
| | Adsorption | 1 | 2022 | 153 | 0.050 |
Why?
| | Exercise Test | 1 | 2025 | 630 | 0.040 |
Why?
| | Titanium | 1 | 2022 | 74 | 0.040 |
Why?
| | Blood Pressure Determination | 2 | 2013 | 145 | 0.040 |
Why?
| | Prevalence | 2 | 2023 | 2875 | 0.040 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2022 | 451 | 0.040 |
Why?
| | Histidine | 1 | 2021 | 66 | 0.040 |
Why?
| | Blood Proteins | 1 | 2022 | 239 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 627 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 457 | 0.040 |
Why?
| | Stents | 2 | 2015 | 564 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2110 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 178 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | Electromyography | 1 | 2022 | 419 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 424 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 101 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2326 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 571 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 587 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 149 | 0.040 |
Why?
| | Self Concept | 1 | 2021 | 254 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2064 | 0.040 |
Why?
| | Obesity | 2 | 2023 | 3118 | 0.040 |
Why?
| | Perfusion | 2 | 2017 | 251 | 0.040 |
Why?
| | User-Computer Interface | 1 | 2019 | 165 | 0.030 |
Why?
| | Models, Biological | 1 | 2006 | 1764 | 0.030 |
Why?
| | Gadolinium | 1 | 2018 | 84 | 0.030 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2017 | 17 | 0.030 |
Why?
| | Myocardium | 1 | 2023 | 935 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 163 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 370 | 0.030 |
Why?
| | Liver Transplantation | 2 | 1994 | 827 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 25 | 0.030 |
Why?
| | Genomic Library | 1 | 2016 | 16 | 0.030 |
Why?
| | Reaction Time | 1 | 1998 | 434 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 690 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2015 | 16 | 0.030 |
Why?
| | Memory | 1 | 1998 | 297 | 0.030 |
Why?
| | Risk | 1 | 2018 | 923 | 0.030 |
Why?
| | Extracellular Fluid | 1 | 2015 | 38 | 0.030 |
Why?
| | Liver Circulation | 1 | 2015 | 12 | 0.030 |
Why?
| | Australia | 1 | 2016 | 291 | 0.030 |
Why?
| | Splenic Artery | 1 | 2015 | 13 | 0.030 |
Why?
| | Elastin | 1 | 2015 | 78 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 515 | 0.030 |
Why?
| | Hepatic Artery | 1 | 2015 | 53 | 0.030 |
Why?
| | Mesenteric Artery, Superior | 1 | 2015 | 28 | 0.030 |
Why?
| | Heart Atria | 1 | 2016 | 141 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2015 | 95 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2069 | 0.030 |
Why?
| | Protein Binding | 1 | 2021 | 2240 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 935 | 0.030 |
Why?
| | Postoperative Period | 1 | 2015 | 351 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 618 | 0.030 |
Why?
| | Organ Preservation Solutions | 1 | 1994 | 46 | 0.030 |
Why?
| | Cell Count | 1 | 2014 | 319 | 0.030 |
Why?
| | Electrons | 1 | 2014 | 80 | 0.030 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 37 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2015 | 356 | 0.020 |
Why?
| | Observational Studies as Topic | 1 | 2013 | 134 | 0.020 |
Why?
| | Organ Preservation | 1 | 1994 | 125 | 0.020 |
Why?
| | Quality Control | 1 | 2013 | 161 | 0.020 |
Why?
| | Pericardium | 1 | 2013 | 59 | 0.020 |
Why?
| | Cyclosporine | 1 | 1994 | 256 | 0.020 |
Why?
| | Tacrolimus | 1 | 1994 | 196 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2094 | 0.020 |
Why?
| | Thermodynamics | 1 | 2014 | 419 | 0.020 |
Why?
| | Silicones | 1 | 2012 | 31 | 0.020 |
Why?
| | Compliance | 1 | 2012 | 50 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 65 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1547 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1925 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1139 | 0.020 |
Why?
| | Forecasting | 1 | 2013 | 390 | 0.020 |
Why?
| | Meglumine | 1 | 2011 | 18 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2012 | 199 | 0.020 |
Why?
| | United States | 2 | 2018 | 16126 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 341 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 525 | 0.020 |
Why?
| | Pyocyanine | 1 | 1989 | 5 | 0.020 |
Why?
| | Phenazines | 1 | 1989 | 17 | 0.020 |
Why?
| | Cognition | 1 | 1998 | 1271 | 0.020 |
Why?
| | Mucociliary Clearance | 1 | 1989 | 44 | 0.020 |
Why?
| | Trachea | 1 | 1989 | 258 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2006 | 98 | 0.010 |
Why?
| | Microbubbles | 1 | 2006 | 53 | 0.010 |
Why?
| | Nanotubes | 1 | 2006 | 46 | 0.010 |
Why?
| | Liver | 1 | 1994 | 1899 | 0.010 |
Why?
| | Mice | 1 | 2022 | 18356 | 0.010 |
Why?
| | Particle Size | 1 | 2006 | 381 | 0.010 |
Why?
| | Cardioplegic Solutions | 1 | 1994 | 3 | 0.010 |
Why?
| | Raffinose | 1 | 1994 | 29 | 0.010 |
Why?
| | Allopurinol | 1 | 1994 | 70 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 255 | 0.010 |
Why?
| | Glutathione | 1 | 1994 | 370 | 0.010 |
Why?
| | Graft Survival | 1 | 1994 | 519 | 0.010 |
Why?
| | Tissue and Organ Procurement | 1 | 1994 | 343 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1989 | 159 | 0.000 |
Why?
|
|
Barker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|